T. Asano et al., ALTERED MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR GENE-EXPRESSION INHUMAN GLIOBLASTOMA CELL-LINES INCREASED THEIR SUSCEPTIBILITY TO CYTOTOXICITY, Journal of leukocyte biology, 59(6), 1996, pp. 916-924
A cDNA encoding for human monocyte chemotactic and activating factor (
MCAF) was ligated into the retroviral vector pLXSN. These pMCAF-LXSN a
nd antisense p-antiMCAF-LXSN vectors were transfected into HBT20 and H
BT28 human brain tumor cells. HBT28 cells constitutively express high
amounts of MCAF, whereas HBT20 cells express much less MCAF. HBT20 cel
ls transfected with pMCAF-LXSN (HBT20-MCAF) showed significantly highe
r MCAF mRNA expression and MCAF protein production than the HBT20-pare
nt of HBT20 cells transfected with control vector (HBT20-LXSN). In con
trast, supernatant from HBT28 cells transfected with p-antiMCAF-LXSN (
HBT28-antiMCAF) contained less MCAF than HBT28-parent, HBT20-LXSN, and
HBT20 cells. Activated human monocyte killed HBT20-antiMCAF cells (P<
0.02), whereas HBT28-antiMCAF cells were killed more efficiently by ac
tivated monocytes compared with HBT28-parent, HBT28-LXSN, and HBT28-MC
AF cells (P<0.05). Cultured supernatants from activated monocytes plus
HBT28-antiMCAF cells inhibited the growth of HBT20 and HBT28 cells, r
espectively. Altered MCAF expression can therefore enhance the ability
of activated monocytes to kill brain tumor cells. This increased cyto
toxicity is partially dependent upon the basal state of MCAF in the in
dividual tumor cells.